1. Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders?

   • A. A. M. Wilde
   • P. Langendijk

   editorial Pages: 127 - 128

2. Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation?

   • C. J. W. Borleffs
   • A. A. M. Wilde
   • A. Mosterd

   original article Pages: 129 - 132

   

3. Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study

   • C. A. Geluk
   • R. A. Tio
   • F. Zijlstra

   original article Pages: 133 - 141

   

4. Exercise prescription for patients with a Fontan circulation: current evidence and future directions

   • T. Takken
   • H. J. Hulzebos
   • J. L. M. Strengers

   review article Pages: 142 - 147

   

5. Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapy

   • P. A. Gurbel
   • D. E. Kandzari

   special article Pages: 148 - 150

6. Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally

   • J. K. Jongman
   • N. Jepkes-Bruin
   • A. Elvan

   case report Pages: 151 - 154

   

7. Crossing coronary arteries

   • E. S. Zegers
   • M. W. A. Verkroost
   • F. W. A. Verheugt

   imaging in cardiology Pages: 155 - 156

   

8. Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy

   • T. Germans
   • A. A. M. Wilde
   • A. C. van Rossum

   editorial Pages: 161 - 163